D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$655M |
| 2 |
NVIDIA
NVDA
|
+$579M |
| 3 |
Amazon
AMZN
|
+$425M |
| 4 |
ConocoPhillips
COP
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$380M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$868M |
| 2 |
Meta Platforms (Facebook)
META
|
+$554M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Pfizer
PFE
|
+$316M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPRX
2076
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $522K | ﹤0.01% |
86,646
+71,703
| +480% | +$432K |
|
2077
Zai Lab
ZLAB
$3.58B
| $521K | ﹤0.01% |
+14,933
| New | +$521K |
|
2078
Energy Select Sector SPDR Fund
XLE
$27.1B
| $520K | ﹤0.01% |
+8,168
| New | +$520K |
|
2079
Fresenius Medical Care
FMS
$14.8B
| $518K | ﹤0.01% |
13,184
-826
| -6% | -$32.5K |
|
2080
Royal Gold
RGLD
$12.4B
| $518K | ﹤0.01% |
5,055
+1,403
| +38% | +$144K |
|
2081
BancFirst
BANF
$4.47B
| $515K | ﹤0.01% |
9,245
+127
| +1% | +$7.08K |
|
2082
Nucor
NUE
$33.2B
| $515K | ﹤0.01% |
+9,344
| New | +$515K |
|
2083
Esperion Therapeutics
ESPR
$550M
| $514K | ﹤0.01% |
+11,034
| New | +$514K |
|
2084
SITE Centers
SITC
$474M
| $512K | ﹤0.01% |
+49,583
| New | +$512K |
|
2085
Darden Restaurants
DRI
$24.8B
| $511K | ﹤0.01% |
4,200
-145,396
| -97% | -$17.7M |
|
|
MAXR
2086
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $510K | ﹤0.01% |
65,044
+39,704
| +157% | +$311K |
|
2087
SAP
SAP
$300B
| $509K | ﹤0.01% |
3,719
+719
| +24% | +$98.4K |
|
2088
BrightView Holdings
BV
$1.34B
| $508K | ﹤0.01% |
+27,171
| New | +$508K |
|
|
AIG.WS
2089
DELISTED
American International Group, Inc.
AIG.WS
| $508K | ﹤0.01% |
41,284
| – | – |
|
2090
Ryder
R
$7.71B
| $507K | ﹤0.01% |
8,695
-31,849
| -79% | -$1.86M |
|
|
AUO
2091
DELISTED
AU Optronics Corp
AUO
| $507K | ﹤0.01% |
171,153
+111,851
| +189% | +$331K |
|
2092
Banco de Chile
BCH
$15.6B
| $505K | ﹤0.01% |
16,999
+4,771
| +39% | +$142K |
|
2093
Mettler-Toledo International
MTD
$26.5B
| $504K | ﹤0.01% |
600
+100
| +20% | +$84K |
|
|
CLLS
2094
Cellectis
CLLS
$305M
| $502K | ﹤0.01% |
+32,200
| New | +$502K |
|
2095
Spok Holdings
SPOK
$362M
| $501K | ﹤0.01% |
33,313
-38,642
| -54% | -$581K |
|
2096
Kellanova
K
$27.6B
| $498K | ﹤0.01% |
9,892
-779,479
| -99% | -$39.2M |
|
|
ATNX
2097
DELISTED
Athenex, Inc. Common Stock
ATNX
| $494K | ﹤0.01% |
+1,249
| New | +$494K |
|
2098
NVE Corp
NVEC
$323M
| $492K | ﹤0.01% |
7,068
+4,191
| +146% | +$292K |
|
2099
Clean Energy Fuels
CLNE
$550M
| $491K | ﹤0.01% |
183,917
-373,582
| -67% | -$997K |
|
2100
Sensient Technologies
SXT
$4.61B
| $489K | ﹤0.01% |
6,652
-8,421
| -56% | -$619K |
|